John H. Johnson, formerly of Johnson & Johnson, has been named chief executive officer, ImClone Systems, effective August 27th. Mr. Johnson has more than two decades of executive and operational management experience in the biopharmaceutical and healthcare industries. He has held senior management positions of increasing responsibility at J&J and most recently served as company group chairman of its worldwide biopharmaceuticals unit, where he was responsible for the biotechnology, immuno...